Trial Profile
Candesartan/Hydrochlorothiazide Versus High-dose Candesartan for the Clinical Assessment of N-terminal pro-B Type Natriuretic Peptide Levels and Cardio-renal Protective Effects: A comparative study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary) ; Candesartan cilexetil/hydrochlorothiazide (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 15 Apr 2016 Status changed from active, no longer recruiting to completed.
- 26 Mar 2011 New trial record